A Long-Term Study to Evaluate the Safety of Asoprisnil in the Treatment of Women With Endometriosis From Study M01-398

• Status: Completed
• Trial end date: 2004-07-01
• Target enrollment: 0
• Participant gender: Female

Summary

The objective of this study is to determine the long-term safety of asoprisnil 5 mg for 12 months in women with endometriosis from study M01-398.

• Phase: Phase 2
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Abbott

Criteria

Inclusion Criteria:

• Completed 3 months of dosing and Month 3 procedures in study M01-398

• Otherwise in good health

• Month 3 (M01-398) ultrasound reveals no significant gynecologic disorder

Exclusion Criteria:

• Any abnormal lab or procedure result the study-doctor considers important

• Anticipated need for excluded hormonal therapy or unapproved narcotics